MediciNova
MNOV
$1.31
Share price
-0.76%
Change (1 day)
-38.21%
Change (1 year)
Categories
MediciNova (MNOV) - Cash on Hand
Cash on Hand as of December 2023 : $50.99 M
According to MediciNova's latest financial reports the company has $50.99 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
MediciNova - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $50.99 M | -12.8% |
| 2022-12-31 | $58.48 M | -18.12% |
| 2021-12-31 | $71.43 M | 18.98% |
| 2020-12-31 | $60.03 M | -5.89% |
| 2019-12-31 | $63.79 M | 2.37% |
| 2018-12-31 | $62.31 M | 122.61% |
| 2017-12-31 | $27.99 M | 16.06% |
| 2016-12-31 | $24.11 M | 9.25% |
| 2015-12-31 | $22.07 M | 89.18% |
| 2014-12-31 | $11.66 M | 74.16% |
| 2013-12-31 | $6.7 M | 67.07% |
| 2012-12-31 | $4.01 M | -73.43% |
| 2011-12-31 | $15.09 M | -47.73% |
| 2010-12-31 | $28.87 M | -37.3% |
| 2009-12-31 | $46.05 M | 138.65% |
| 2008-12-31 | $19.29 M | -72.68% |
| 2007-12-31 | $70.63 M | -32.11% |
| 2006-12-31 | $0.10 B | -24.98% |
| 2005-12-31 | $0.13 B | 173.03% |
| 2004-12-31 | $50.8 M | 825.23% |
| 2003-12-31 | $5.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 27,276.79% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $2.92 B | 5,640.66% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 19,367.17% | 🇫🇷 France |
 Titan Pharmaceuticals
TTNP | $8.09 M | -84.13% | 🇺🇸 USA |
 Alkermes ALKS | $0.77 B | 1,416.67% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 6,225.56% | 🇮🇱 Israel |